当前位置: 首页 > 期刊 > 《风湿病与关节炎》 > 2019年第2期
编号:13325005
甲氨蝶呤治疗类风湿关节炎的时间治疗学临床研究(4)
http://www.100md.com 2019年2月1日 《风湿病与关节炎》 2019年第2期
     [16] NAIR SC,JACOBS JW,BAKKER MF,et al.Determining the lowest optimally effective methotrexate dose for individual RA patients using their dose response relation in a tight control treatment approach[J].PLoS One,2016,11(3):e0148791.

    [17] LAMPROPOULOS CE,ORFANOS P,BOURNIA VK,et al.Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents:a real world study[J].Clin Exp Rheumatol,2015,33(2):216-224.

    [18] BRANCO JC,BARCELOS A,DE ARA?JO FP,et al.Utilization of subcutaneous methotrexate in rheumatoid arthritis patients after failure or intolerance to oral methotrexate:a multicenter cohort study[J].Adv Ther,2016,33(1):46-57.

    [19] WANG X,YAN X,WANG F,et al.Role of methotrexate chronotherapy in collagen-induced rheumatoid arthritis in rats[J].Z Rheumatol,2018,77(3):249-255.

    [20] TO H,YOSHIMATSU H,TOMONARI M,et al.Methotrexate chronotherapy is effective against rheumatoid arthritis[J].Chronobiol Int,2011,28(3):267-274.

    收稿日期:2018-10-15;修回日期:2018-11-10, 百拇医药(王志强 张晓刚 马旭 张明明 刘彦卿 李振彬)
上一页1 2 3 4